Table 4.
AR symptom scores at baseline and follow-up visits among enrolled patients #.
| Subscale | Examination | A Group (n = 28) |
B Group (n = 31) |
C Group (n = 31) |
PLC Group (n = 32) |
p |
|---|---|---|---|---|---|---|
| Sneezing | Visit 2 | 1.69 (0.77) | 1.61 (0.67) | 1.49 (0.79) | 1.75 (0.64) | 0.527 |
| Visit 3 | 1.61 (0.71) | 1.20 (0.57) a | 1.43 (0.83) | 1.67 (0.67) | 0.045 e | |
| Visit 4 | 1.68 (0.75) | 1.19 (0.70) a | 1.41 (0.83) | 1.40 (0.65) | 0.090 | |
| Visit 5 | 1.51 (0.74) | 1.02 (0.66) a | 1.35 (0.96) | 1.50 (0.66) | 0.049 e | |
| Visit 6 | 1.33 (0.76) | 1.08 (0.68) a | 1.06 (0.82) ab | 1.56 (0.82) | 0.033 e | |
| Rhinorrhea | Visit 2 | 1.83 (0.55) | 1.81 (0.68) | 1.69 (0.70) | 1.95 (0.60) | 0.435 |
| Visit 3 | 1.71 (0.67) | 1.73 (0.83) | 1.51 (0.86) | 1.95 (0.75) | 0.170 | |
| Visit 4 | 1.69 (0.71) | 1.42 (0.80) a | 1.39 (0.76) | 1.65 (0.66) | 0.252 | |
| Visit 5 | 1.37 (0.73) | 1.20 (0.72) ab | 1.24 (1.00) | 1.59 (0.69) | 0.203 | |
| Visit 6 | 1.42 (0.81) | 1.11 (0.67) ab | 1.24 (0.99) | 1.44 (0.75) | 0.320 | |
| Nasal pruritus | Visit 2 | 1.73 (0.70) | 1.72 (0.53) | 1.69 (0.67) | 1.70 (0.79) | 0.997 |
| Visit 3 | 1.54 (0.83) | 1.42 (0.73) | 1.35 (0.67) | 1.65 (0.80) | 0.415 | |
| Visit 4 | 1.43 (0.81) | 1.34 (0.78) a | 1.24 (0.59) a | 1.51 (0.72) | 0.466 | |
| Visit 5 | 1.24 (0.64) a | 1.09 (0.64) a | 1.11 (0.78) a | 1.47 (0.75) | 0.123 | |
| Visit 6 | 1.08 (0.77) a | 1.08 (0.80) a | 1.09 (0.75) a | 1.33 (0.89) | 0.520 | |
| Nasal congestion | Visit 2 | 2.10 (0.63) | 1.97 (0.66) | 2.04 (0.71) | 2.04 (0.61) | 0.880 |
| Visit 3 | 1.87 (0.74) | 1.87 (0.82) | 1.86 (0.88) | 2.07 (0.76) | 0.663 | |
| Visit 4 | 1.87 (0.81) | 1.60 (0.78) | 1.72 (0.64) | 1.84 (0.72) | 0.476 | |
| Visit 5 | 1.33 (0.71) ab | 1.35 (0.88) a | 1.47 (0.89) a | 1.77 (0.84) | 0.154 | |
| Visit 6 | 1.29 (0.73) abc | 1.15 (0.88) abc | 1.19 (0.90) abc | 1.48 (0.84) a | 0.414 | |
| TNSS | Visit 2 | 7.34 (1.44) | 7.11 (1.74) | 6.92 (1.57) | 7.44 (1.56) | 0.559 |
| Visit 3 | 6.74 (2.01) | 6.23 (2.21) | 6.15 (2.51) | 7.35 (2.24) | 0.135 | |
| Visit 4 | 6.68 (2.45) | 5.54 (2.50) a | 5.77 (1.95) a | 6.40 (2.05) | 0.174 | |
| Visit 5 | 5.44 (2.13) a | 4.67 (2.41) ab | 5.18 (2.97) a | 6.33 (2.36) | 0.066 | |
| Visit 6 | 5.12 (2.44) abc | 4.42 (2.39) ab | 4.57 (3.00) abc | 5.56 (2.49) | 0.286 |
# Severity of each symptom was measured on a 4-point scale: 0 = absent; 1 = mild; 2 = moderate; 3 = severe. Scores for each symptom were added to obtain the TNSS. Data were presented as mean (standard deviation). a p < 0.05, intragroup comparisons (visit 6 vs. visit 2, visit 5 vs. visit 2, visit 4 vs. visit 2, visit 3 vs. visit 2 in each group). b p < 0.05, intragroup comparisons (visit 6 vs. visit 3, visit 5 vs. visit 3, visit 4 vs. visit 3). c p < 0.05, intragroup comparisons (visit 6 vs. visit 4, visit 5 vs. visit 4). e p < 0.05, intragroup comparisons (difference between the four groups).